Cathie Wood Invests in CoreWeave Amid AI Surge

• Cathie Wood’s Ark Investment Management added $6.9 million to CoreWeave, a cloud infrastructure provider for AI and machine learning.
• Wood’s ARK Invest ETFs also reduced positions in Teradyne and Strata Critical Medical while increasing stakes in biotech and AI companies.
• Ark ETFs have a long-term bullish outlook on AI advancements and their impact on global economic growth.

Cathie Wood, CEO of Ark Investment Management, has recently allocated $6.9 million into CoreWeave (NASDAQ:CRWV), a cloud infrastructure company backed by Nvidia that provides GPU-powered computing for AI and machine learning. This move highlights her continued focus on high-growth, technology-driven sectors and aligns with the broader market trend of increased demand for AI infrastructure. With CoreWeave’s revenue growing 110% year over year in 2026, Wood’s investment appears to underscore her confidence in the company’s potential to benefit from the surging AI adoption. Analysts have upgraded CoreWeave to 'buy,' citing its strategic partnerships with tech giants like Google and Microsoft.

Why Is Cathie Wood Buying Tech Stock Right Now?

Cathie Wood has long positioned herself as a bullish advocate for disruptive technologies, with her flagship Ark Innovation ETF (ARKK) heavily focused on AI, robotics, and blockchain. The recent investment in CoreWeave fits into this broader strategy. Wood believes that AI advancements will significantly boost global GDP growth, pushing it to 7–8% annually. This view is supported by the declining costs of AI training and inference, which are making the technology more accessible and scalable. CoreWeave’s role in providing optimized GPU resources is critical for AI developers and researchers, making it an attractive investment for Ark.

Despite the positive outlook, Ark’s investments have not been without volatility. ARKK, for instance, dropped 12% in the latest quarter, its worst performance since early 2025. This decline was partly attributed to its heavy exposure to Tesla (TSLA), which has seen mixed performance due to market uncertainty and regulatory challenges. However, Wood remains confident in Tesla’s long-term potential, particularly in autonomous mobility and humanoid robotics. She has even projected a stock price of $2,600 for Tesla by 2029.

How Are Ark ETFs Shaping the Future of AI and Cloud Investments?

Ark’s recent portfolio adjustments reveal a strategic rebalancing of its holdings, with a clear tilt toward AI and cloud infrastructure. In addition to CoreWeave, the ETFs added positions in companies like Oklo and GeneDx, signaling a growing interest in clean energy and genomics. Meanwhile, shares in Teradyne and Strata Critical Medical were sold, reflecting a more cautious approach toward some of its previous high-tech bets.

Wood has also expressed interest in OpenAI, with discussions underway about potential public access to ownership in the company. This aligns with Ark’s broader goal of democratizing access to high-impact innovation and could represent a new avenue for investors seeking exposure to AI developments. In the healthcare space, Ark has increased its stake in GeneDx Holdings (WGS), a company focused on precision medicine and genomic testing.

Overall, Cathie Wood’s investment decisions reflect a long-term vision centered on the transformative potential of AI and related technologies. While short-term market volatility remains a challenge, her strategy emphasizes capturing growth from disruptive innovations that are reshaping industries and economies.